which has more side effects semaglutide or tirzepatide When it comes to the different types of GLP-1s, like vs. semaglutide, what's the difference? Our endocrine clinical pharmacist explains Tirzepatide vs Semaglutide 2026: 22%

For over 14 years, we have been a trusted partner in our community, helping men and women achieve their health and wellness goals through doctor-supervised medical weight loss, advanced body contouring, and aesthetic treatments

Patients with a personal or family history of medullary thyroid carcinoma should not take semaglutide, as animal studies have shown an association between GLP-1 agonists and thyroid C-cell tumors

What to keep in mind

kff.org (May 2024 baseline, 6 percent: kff.org) Circana, GLP-1 medication users to represent 35 percent of US food and beverage sales by 2030, November 2025: GLP-1 households are about 23 percent of US households today

Tirzepatide is a medication that represents a significant advancement in metabolic health

Our way of working focuses on knowing your personal needs, goals, and challenges